Epilepsy is one of the most common neurological disorders in humans. The etiology of epilepsy is complex, with the contribution of both environmental and genetic factors. Linkage analysis and candidate gene studies have enabled the discovery of several epilepsy genes, mutations in which cause rare, autosomal dominant or sporadic forms of epilepsy. Despite these advances, for the vast majority of individuals with epilepsy, the genetic cause is unknown. Recent advances in technology now permit genome-wide analyses for both copy number and sequence changes. Unlike genome-wide studies in many neurodevelopmental disorders, there are no published genome-wide studies in epilepsy to date. The overall goal of this study is to use genomic approaches, including array comparative genomic hybridization and whole exome sequencing, to identify novel candidate genes for epilepsy. We will perform genome-wide array CGH analysis for copy number changes in a cohort of 2000 individuals with epilepsy. We will also use next- generation sequencing technology to perform exome sequencing to identify mutations in a subset of individuals with severe childhood-onset encephalopathy. Each of these whole-genome technologies offers an unbiased approach for identifying novel candidate genes and pathways for epilepsy. We will then use the results of these studies to inform selection of candidate genes for resequencing in 500 affected individuals. The discovery of novel genes and pathways in epilepsy using the genomic approaches within this proposal will further our understanding of brain development and epileptogenesis and allow better prognosis and recurrence risk counseling for families.
Epilepsy is one of the most common neurological disorders in humans, affecting up to 3% of the population. Although it is clear that there is a strong genetic component for epilepsy, there are still only a few genes known. This research will identify new genes and genetic pathways in epilepsy and will directly benefit individuals with epilepsy and their families through improved diagnostic, prognostic and recurrence risk information. Greater understanding of the genes involved in normal development and function of the brain will facilitate improved therapies for this common disorder and benefit society as a whole.
| Ottman, Ruth; Freyer, Catharine; Mefford, Heather C et al. (2018) Return of individual results in epilepsy genomic research: A view from the field. Epilepsia 59:1635-1642 |
| Howell, Katherine B; Eggers, Stefanie; Dalziel, Kim et al. (2018) A population-based cost-effectiveness study of early genetic testing in severe epilepsies of infancy. Epilepsia 59:1177-1187 |
| Jansen, Sandra; Hoischen, Alexander; Coe, Bradley P et al. (2018) A genotype-first approach identifies an intellectual disability-overweight syndrome caused by PHIP haploinsufficiency. Eur J Hum Genet 26:54-63 |
| Myers, Candace T; Hollingsworth, Georgina; Muir, Alison M et al. (2018) Parental Mosaicism in ""De Novo"" Epileptic Encephalopathies. N Engl J Med 378:1646-1648 |
| Chatron, Nicolas; Møller, Rikke S; Champaigne, Neena L et al. (2018) The epilepsy phenotypic spectrum associated with a recurrent CUX2 variant. Ann Neurol 83:926-934 |
| Carvill, Gemma L; Liu, Aijie; Mandelstam, Simone et al. (2018) Severe infantile onset developmental and epileptic encephalopathy caused by mutations in autophagy gene WDR45. Epilepsia 59:e5-e13 |
| Johannesen, Katrine M; Gardella, Elena; Linnankivi, Tarja et al. (2018) Defining the phenotypic spectrum of SLC6A1 mutations. Epilepsia 59:389-402 |
| Myers, Candace T; Stong, Nicholas; Mountier, Emily I et al. (2017) De Novo Mutations in PPP3CA Cause Severe Neurodevelopmental Disease with Seizures. Am J Hum Genet 101:516-524 |
| EuroEPINOMICS-RES Consortium. Electronic address: euroepinomics-RES@ua.ac.be; Epilepsy Phenome/Genome Project; Epi4K Consortium et al. (2017) De Novo Mutations in Synaptic Transmission Genes Including DNM1 Cause Epileptic Encephalopathies. Am J Hum Genet 100:179 |
| Sadleir, Lynette G; Mountier, Emily I; Gill, Deepak et al. (2017) Not all SCN1A epileptic encephalopathies are Dravet syndrome: Early profound Thr226Met phenotype. Neurology 89:1035-1042 |
Showing the most recent 10 out of 36 publications
